Navigation Links
Alzheimer's drug developer lands $1.2M in venture funding

Madison, Wis. - Mithridion, Inc., a biopharmaceutical start up that is developing drugs to disrupt the progress of Alzheimer's disease, has closed an additional $1.2 million of Series A funding led by Madison's Venture Investors.

The latest round of funding brings the total equity capital raised in th......

Full article >>> s, and the continued support of WARF and Rosetta Partners.

"It's a great leap forward for our company in getting Venture Investors, a professional investment firm," Twose said. "It's not only a leap forward in terms of getting the funding, it's the quality of the investors they bring in."

The new funding will be used to advance Mithridion's drug lead, a prototype drug that will b......

Full article >>> ts discovery is based on animal models used in Alzheimer's research. "It was noted that they [the animals] did not develop the full form of Alzheimer's, which caused investors to ask why?" Neis said.

......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 04/17/07


Related biology technology :

1. Biotech firm has strokes, Alzheimers in its sights
2. Mithridion wins grants for Alzheimers research
3. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
4. Alzheimers drug market to hit $5.5 billion by 2009, study says
5. Marshfield study mixes DNA into electronic medical record to screen for Alzheimers
6. UW Alzheimers researchers found company; privacy law; Science Expeditions
7. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
8. Discovery may halt progression of Alzheimers
9. Milwaukee software developer gains bottom line, loses waistline
10. Emerging game developer begins work on prototypes
11. Metavante to buy California software developer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... ... December 02, 2016 , ... ... biotechnology companies dedicated to collaboratively developing improved chemistry, manufacturing and control technologies ... portable online UHPLC, with robust, probe-based sampling. , Online liquid chromatography ...
(Date:12/2/2016)... 1, 2016   SurePure, Inc. (OTCQB: SURP) ... the Company has concluded an agreement with Tamarack Biotics ... 90-day period to acquire units of the Company,s patented ... 3.7 million.  Concurrently with the option, ... which Tamarack will seek regulatory approvals in ...
(Date:12/2/2016)... world leader in rapid infectious disease tests, introduced the Company,s newest product, the INSTI ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , bioLytical was invited by the Clinton ... HIV Self Test to 350 pharmacy representatives in Nairobi and ...
(Date:11/30/2016)... , Nov. 30, 2016  GenomOncology today announced the appointment ... of Medical Affairs.  Dr. Coleman will oversee ... company,s proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular ... sequencing data and clinical decision support, from quality control through ... , , ...
Breaking Biology Technology:
(Date:11/17/2016)... LONDON , Nov. 17, 2016 Global Market ... and Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market ... Geographical analysis for Private Biobanks shows the highest Compounded Annual ... Asia-Pacific region during the analysis period 2014-2020. ... a CAGR of 9.95% followed by Europe ...
(Date:11/14/2016)... Nov. 14, 2016  xG Technology, Inc. ("xG" or ... critical wireless communications for use in challenging operating environments, ... 30, 2016. Management will hold a conference call to ... p.m. Eastern Time (details below). Key Recent ... $16 million binding agreement to acquire Vislink Communication Systems. ...
(Date:6/22/2016)... , June 22, 2016 On Monday, ... call to industry to share solutions for the Biometric ... U.S. Customs and Border Protection (CBP), explains that CBP ... are departing the United States , ... and to defeat imposters. Logo - ...
Breaking Biology News(10 mins):